Wikipedia:Contributor copyright investigations/20240516
This page has been removed from search engines' indexes.
Instructions
All contributors with no history of copyright problems are welcome to contribute to clean up. Contributors who are the subject of a contributor copyright investigation are among contributors with a history of copyright problems and so are not welcome to directly evaluate their own or others' copyright violations in CCIs. They are welcome to assist with rewriting any problems identified, and are encouraged to assist with accessing offline and paywalled sources.
If contributors have been shown to have a history of extensive copyright violation, it may be assumed without further evidence that all of their major contributions are copyright violations, and they may be removed indiscriminately in accordance with Wikipedia:Copyright violations. Contributors who are the subject of a contributor copyright investigation are among contributors who have been shown to have a history of extensive copyright violation and so all of the below listed contributions may be removed indiscriminately. However, to avoid collateral damage, efforts should be made when possible to verify infringement before removal.
When every section is completed, please alter the listing for this CCI at Template:CCIlist to include the tag "completed=yes". This will alert a clerk that the listing needs to be archived.
{{CCI-open|Contributor name|Day Month Year|completed=yes}}
Text
- Examine the article or the diffs linked below.
- If the contributor has added creative content, either evaluate it carefully for copyright concerns or remove it.
- Evaluating for copyright concerns may include checking the listed sources, spot-checking using search engines, google books, or archives, and looking for major differences in writing style. The background may give some indication of the kinds of copyright concerns that have been previously detected. For older text, mirrors of Wikipedia content may make determining which came first difficult. It may be helpful to look for significant changes to the text after it was entered. Searching for the earlier form of text can help eliminate later mirrors. If you cannot determine which came first, text should be removed presumptively, since there is an established history of copying with the editor in question.
- If you remove large portions of text presumptively, place
{{subst:CCI|name=Contributor name}}
on the article's talk page. - If you specifically locate infringement and remove large portions of the text (or revert to a previous clean version), place
{{subst:cclean}}
on the article's talk page. The url parameter may be optionally used to indicate source. - If there is insufficient creative content on the page for it to survive the removal of the text or it is impossible to salvage, replace it with
{{subst:copyvio}}
, linking to the investigation subpage in the url parameter. List the article as instructed at the copyright problems board, but you do not need to notify the contributor. Your note on the CCI investigation page serves that purpose. - To tag an article created by the contributor for presumptive deletion, place
{{subst:copyvio|url=see talk}}
on the article's face and{{subst:CCId|name=Contributor name}}
on the article's talk page. List the article as instructed at the copyright problems board, but you do not need to notify the contributor.
- After examining an article:
- replace the diffs after the colon on the listing with indication of whether a problem was found (add {{y}}) or not (add {{n}}). If the article is blanked and may be deleted, please indicate as much after the {{y}}. The {{?}} template may be used for articles where you did not determine whether or not a violation occurred, but are prepared to remove the article from consideration – either because the material is no longer present in the article, or it is adequately paraphrased so as to no longer be a violation (please specify which).
- Follow with your username and the time to indicate to others that the article has been evaluated and appropriately addressed. This is automatically generated by four tildes (~~~~)
- If a section is complete, consider collapsing it by placing {{collapse top}} and {{collapse bottom}} beneath the section header and after the final listing.
Background
Dmitry Dzhagarov
- Dmitry Dzhagarov (talk | contribs | deleted contribs | logs | block | block log)
Pages 1 to 20
- World Calendar (1 edit): (+13382)
- Exosome (vesicle) (1 edit): (+4694)
- Moscow Society of Naturalists (3 edits): (+4182)(+852)(+166)
- Induced stem cells (168 edits): (+3729)(+3246)(+2992)(+2682)(+2372)(+2212)(+2118)(+2027)(+2013)(+1916)(+1884)(+1747)(+1726)(+1697)(+1625)(+1574)(+1513)(+1463)(+1445)(+1392)(+1346)(+1316)(+1309)(+1295)(+1288)(+1255)(+1233)(+1138)(+1117)(+1111)(+1108)(+1098)(+1094)(+1077)(+1061)(+1058)(+1051)(+1043)(+1040)(+1016)(+993)(+982)(+982)(+982)(+975)(+969)(+964)(+964)(+961)(+955)(+950)(+946)(+902)(+889)(+867)(+865)(+837)(+825)(+806)(+806)(+802)(+785)(+773)(+755)(+747)(+731)(+686)(+685)(+675)(+672)(+664)(+662)(+631)(+629)(+623)(+621)(+603)(+601)(+591)(+588)(+585)(+583)(+580)(+577)(+567)(+564)(+558)(+556)(+551)(+543)(+535)(+520)(+516)(+512)(+508)(+499)(+497)(+497)(+496)(+494)(+494)(+487)(+486)(+477)(+468)(+466)(+465)(+462)(+444)(+433)(+419)(+414)(+409)(+407)(+398)(+393)(+370)(+355)(+353)(+353)(+350)(+347)(+339)(+338)(+335)(+327)(+322)(+320)(+312)(+310)(+310)(+307)(+307)(+304)(+300)(+297)(+292)(+289)(+289)(+289)(+283)(+278)(+278)(+278)(+271)(+269)(+266)(+264)(+256)(+251)(+244)(+234)(+227)(+221)(+220)(+219)(+216)(+200)(+198)(+193)(+191)(+189)(+188)(+169)(+166)(+163)(+161)(+159)
- N DCAF11 (3 edits): (+3497)(+1178)(+450)
- MYC (1 edit): (+3309)
- Epigenome editing (3 edits): (+2895)(+727)(+584)
- N Embelin (2 edits): (+2859)(+645)
- N Paul Niehans (4 edits): (+2855)(+388)(+387)(+318)
- Atherosclerosis (2 edits): (+2479)(+925)
- 3C-like protease (1 edit): (+2452)
- Epigenetic clock (10 edits): (+2362)(+1212)(+858)(+555)(+514)(+498)(+456)(+445)(+310)(+244)
- Intestinal permeability (1 edit): (+2241)
- Senotherapy (15 edits): (+2165)(+1861)(+1797)(+1797)(+1252)(+1196)(+594)(+544)(+419)(+375)(+282)(+272)(+260)(+224)(+210)
- N Coibamide A (1 edit): (+2128)
- N Agglutination-PCR (3 edits): (+2109)(+993)(+688)
- Humanized mouse (4 edits): (+2107)(+939)(+922)(+246)
- V-erbA-related gene (1 edit): (+2029)
- N METRNL (2 edits): (+1968)(+1429)
- MALAT1 (4 edits): (+1922)(+615)(+555)(+338)
Pages 21 to 40
- Islet cell transplantation (1 edit): (+1766)
- LINE1 (3 edits): (+1707)(+685)(+532)
- Transforming growth factor beta (1 edit): (+1685)
- DOT1L (1 edit): (+1655)
- CAR T cell (2 edits): (+1584)(+1535)
- BPIFB4 (2 edits): (+1548)(+1021)
- Frailty syndrome (1 edit): (+1517)
- Prazosin (1 edit): (+1475)
- Single-cell analysis (1 edit): (+1446)
- CD47 (2 edits): (+1413)(+195)
- Tomatine (1 edit): (+1385)
- Rejuvenation (1 edit): (+1371)
- Cyclodextrin (5 edits): (+1344)(+1288)(+871)(+722)(+290)
- Somatic cell nuclear transfer (1 edit): (+1344)
- Transcriptomics technologies (1 edit): (+1337)
- Inflammaging (3 edits): (+1316)(+464)(+327)
- Statin (1 edit): (+1294)
- COVID-19 vaccine (1 edit): (+1289)
- COVID-19 (1 edit): (+1288)
- Agrin (1 edit): (+1279)
Pages 41 to 60
- Sirtuin 7 (1 edit): (+1278)
- Mdm2 (2 edits): (+1262)(+1253)
- Cancer cell (1 edit): (+1250)
- Pentoxifylline (1 edit): (+1218)
- Isofalcarintriol (2 edits): (+1216)(+532)
- Senescence-associated secretory phenotype (1 edit): (+1209)
- Liquiritin (1 edit): (+1205)
- Life extension (2 edits): (+1191)(+353)
- Induced pluripotent stem cell (7 edits): (+1188)(+891)(+699)(+473)(+341)(+286)(+212)
- Glycyrrhizin (2 edits): (+1167)(+948)
- Transcription factor (2 edits): (+1139)(+314)
- COP9 signalosome (2 edits): (+1130)(+316)
- Kojic acid (2 edits): (+1104)(+553)
- Bronchodilator (1 edit): (+1074)
- Abscisic acid (1 edit): (+1072)
- Senolytic (12 edits): (+1066)(+948)(+929)(+762)(+725)(+511)(+476)(+414)(+288)(+284)(+243)(+236)
- TNF inhibitor (1 edit): (+1051)
- CD36 (2 edits): (+1034)(+445)
- PITPNM1 (1 edit): (+1028)
- Celastrol (1 edit): (+1006)
Pages 61 to 80
- Genetically modified food (1 edit): (+1000)
- Cell potency (2 edits): (+998)(+350)
- Serum response factor (3 edits): (+977)(+346)(+333)
- Bedaquiline (1 edit): (+959)
- Anthrax (1 edit): (+944)
- Zoledronic acid (2 edits): (+937)(+671)
- DNA methylation (1 edit): (+930)
- 2-Deoxy-D-glucose (1 edit): (+897)
- Self-microemulsifying drug delivery system (1 edit): (+897)
- Interleukin 6 (2 edits): (+894)(+574)
- DNA-binding domain (2 edits): (+890)(+629)
- Cell nucleus (1 edit): (+886)
- Ashitaba (1 edit): (+885)
- RE1-silencing transcription factor (1 edit): (+877)
- Argonaute (1 edit): (+876)
- Organoid (2 edits): (+873)(+352)
- Icatibant (1 edit): (+870)
- RBM7 (1 edit): (+860)
- Xenotransplantation (1 edit): (+859)
- Effects of parasitic worms on the immune system (2 edits): (+849)(+417)
Pages 81 to 100
- Pyrvinium (1 edit): (+838)
- Long non-coding RNA (3 edits): (+821)(+602)(+598)
- Basigin (1 edit): (+812)
- SUMO protein (2 edits): (+801)(+386)
- GDF6 (1 edit): (+792)
- AP-1 transcription factor (2 edits): (+786)(+483)
- HMGB2 (1 edit): (+781)
- PDCD5 (1 edit): (+771)
- Cubelets (1 edit): (+741)
- MBD3 (1 edit): (+741)
- Gcn4 (1 edit): (+736)
- Interferon beta-1a (1 edit): (+735)
- Epigenetics in insects (2 edits): (+733)(+733)
- FKBP5 (2 edits): (+727)(+398)
- TERF2IP (1 edit): (+727)
- Spironolactone (1 edit): (+723)
- Thiostrepton (1 edit): (+706)
- NFE2L2 (2 edits): (+706)(+456)
- ARID3A (1 edit): (+705)
- PIEZO1 (1 edit): (+704)
Pages 101 to 120
- Sambucus (1 edit): (+703)
- Single-domain antibody (1 edit): (+700)
- FokI (1 edit): (+677)
- Luteolinidin (1 edit): (+673)
- Cinnamtannin B1 (1 edit): (+667)
- Sacubitril/valsartan (1 edit): (+665)
- Chromatin assembly factor 1 (1 edit): (+660)
- Biochanin A (1 edit): (+648)
- Mi-2/NuRD complex (1 edit): (+647)
- Triphala (1 edit): (+646)
- Management of acute coronary syndrome (1 edit): (+645)
- ApoA-I Milano (2 edits): (+641)(+387)
- Artificial organ (2 edits): (+639)(+238)
- Twist-related protein 1 (1 edit): (+633)
- Indy (gene) (1 edit): (+469)
- Lanosterol (1 edit): (+631)
- Aminooxyacetic acid (1 edit): (+626)
- KLF4 (1 edit): (+626)
- J147 (1 edit): (+615)
- Genetically modified organism (1 edit): (+614)
Pages 121 to 140
- Myocardial infarction (1 edit): (+608)
- H3K4me3 (1 edit): (+603)
- PiggyBac transposon system (1 edit): (+597)
- SETDB1 (3 edits): (+588)(+398)(+169)
- Galunisertib (1 edit): (+586)
- Morin (flavonol) (1 edit): (+583)
- FOXO3 (1 edit): (+577)
- Smoothened agonist (1 edit): (+574)
- CRISPR (3 edits): (+573)(+320)(+241)
- RNA interference (1 edit): (+562)
- In vivo bioreactor (2 edits): (+557)(+554)
- Brequinar (1 edit): (+531)
- DKK1 (1 edit): (+528)
- Hormesis (1 edit): (+527)
- Polycomb-group proteins (3 edits): (+477)(+398)(+344)
- Love is in the Bin (1 edit): (+520)
- Carrot (2 edits): (+519)(+383)
- Plerixafor (1 edit): (+515)
- Japanese sea bass (1 edit): (+515)
- Vinegar (1 edit): (+515)
Pages 141 to 160
- Inflammasome (1 edit): (+509)
- Sirtuin 2 (1 edit): (+507)
- Farnesol (1 edit): (+507)
- MTOR inhibitors (1 edit): (+506)
- Versican (1 edit): (+505)
- ISRIB (1 edit): (+498)
- Bouvardin (1 edit): (+494)
- LIM domain (1 edit): (+481)
- RNF5 (1 edit): (+476)
- Leonurus cardiaca (1 edit): (+471)
- Muse cell (3 edits): (+471)(+316)(+298)
- Myosatellite cell (1 edit): (+461)
- Amlexanox (1 edit): (+458)
- SB-431542 (1 edit): (+451)
- Glabridin (1 edit): (+447)
- HER2 (1 edit): (+427)
- Naringenin (1 edit): (+426)
- VASH1 (1 edit): (+422)
- Roflumilast (1 edit): (+422)
- Stimulus-triggered acquisition of pluripotency (1 edit): (+420)
Pages 161 to 180
- Ruxolitinib (2 edits): (+416)(+240)
- Prunetin (1 edit): (+403)
- Cumin (1 edit): (+401)
- Hepatocyte growth factor (1 edit): (+397)
- CDKN2B (1 edit): (+394)
- ATF4 (1 edit): (+389)
- Lysyl oxidase (1 edit): (+387)
- Cyclin D2 (1 edit): (+383)
- GCAT (1 edit): (+381)
- Quebecol (1 edit): (+379)
- Werner syndrome (1 edit): (+377)
- Disease-modifying osteoarthritis drug (1 edit): (+357)
- Navitoclax (1 edit): (+355)
- Homeobox protein SIX1 (1 edit): (+352)
- Mothers against decapentaplegic homolog 3 (1 edit): (+344)
- Cas9 (2 edits): (+344)(+241)
- Sarcopenia (1 edit): (+341)
- Sirtris Pharmaceuticals (1 edit): (+341)
- Genetically modified food controversies (1 edit): (+340)
- Prostaglandin DP1 receptor (1 edit): (+321)
Pages 181 to 200
- BEN domain (1 edit): (+320)
- FGF17 (1 edit): (+313)
- PMEL (gene) (1 edit): (+312)
- PUF60 (1 edit): (+309)
- CCN protein (1 edit): (+307)
- Hippo signaling pathway (2 edits): (+304)(+241)
- STRN (1 edit): (+297)
- PD-L1 (1 edit): (+295)
- Bill Liao (1 edit): (+292)
- Chromatin remodeling (1 edit): (+287)
- CDKN2BAS (1 edit): (+280)
- Apigenin (1 edit): (+280)
- Serge Voronoff (1 edit): (+279)
- Leonurine (1 edit): (+274)
- Freeze drying (1 edit): (+270)
- CBX7 (gene) (1 edit): (+261)
- CD146 (1 edit): (+260)
- Guanylate kinase (1 edit): (+259)
- Signal-regulatory protein alpha (1 edit): (+209)
- MTOR (1 edit): (+256)
Pages 201 to 217
- SOX17 (1 edit): (+254)
- Hyperbaric medicine (1 edit): (+251)
- SESN1 (1 edit): (+248)
- Waxworm (1 edit): (+240)
- Casin (1 edit): (+233)
- CSN (1 edit): (+233)
- Pseudoexfoliation syndrome (1 edit): (+232)
- ADP/ATP translocase 1 (1 edit): (+219)
- Tissue engineering (1 edit): (+215)
- Farnesoid X receptor (1 edit): (+213)
- SYMPK (1 edit): (+209)
- CD9 (1 edit): (+199)
- Histone methylation (1 edit): (+177)
- Unaffiliated (1 edit): (+176)
- Raptor (1 edit): (+168)
- DD (1 edit): (+162)
- Ticagrelor (1 edit): (+157)
This report generated by ContributionSurveyor.java at 2024-05-16T17:48:58.755185121Z. Command line: java org.wikipedia.tools.ContributionSurveyor --user Dmitry Dzhagarov --outfile dump.txt